PubRank

Brian J Czerniecki

Author PubWeight™ 65.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Breast cancer detection based on incremental biochemical and physiological properties of breast cancers: a six-year, two-site study. Acad Radiol 2005 3.33
2 Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI. Med Phys 2005 2.76
3 Identification of high-risk patients among those diagnosed with thin cutaneous melanomas. J Clin Oncol 2007 2.06
4 Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol 2005 1.84
5 Differentiation of benign and malignant breast tumors by in-vivo three-dimensional parallel-plate diffuse optical tomography. J Biomed Opt 2009 1.82
6 Ductal carcinoma in situ: state of the science and roadmap to advance the field. J Clin Oncol 2008 1.74
7 Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 2003 1.70
8 Diffuse optical measurement of blood flow in breast tumors. Opt Lett 2005 1.65
9 Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism. J Immunol 2003 1.50
10 HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer. Cancer Epidemiol Biomarkers Prev 2009 1.46
11 Cutting edge: innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells. J Immunol 2004 1.38
12 Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients. J Clin Oncol 2003 1.34
13 MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology 2003 1.27
14 Differential production of IL-23 and IL-12 by myeloid-derived dendritic cells in response to TLR agonists. J Immunol 2008 1.27
15 Skin-sparing mastectomy and immediate reconstruction is an acceptable treatment option for patients with high-risk breast carcinoma. Cancer 2005 1.22
16 HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ. Cancer 2012 1.18
17 MRI before reexcision surgery in patients with breast cancer. AJR Am J Roentgenol 2004 1.12
18 Trends in immediate breast reconstruction across insurance groups after enactment of breast cancer legislation. Cancer 2013 1.09
19 Reengineering dendritic cell-based anti-cancer vaccines. Immunol Rev 2008 1.09
20 Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma. Cancer 2006 1.08
21 STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells. Blood 2008 1.06
22 A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancer. J Immunother 2012 1.02
23 Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patients. Ann Surg Oncol 2007 1.02
24 A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside. Clin Cancer Res 2013 1.01
25 Predictors of regional nodal disease in patients with thin melanomas. Ann Surg Oncol 2006 1.00
26 Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses. PLoS One 2011 0.97
27 Human leukocyte antigen-A2-restricted CTL responses to mutated BRAF peptides in melanoma patients. Cancer Res 2006 0.96
28 Factors influencing surgical and adjuvant therapy in stage I breast cancer: a SEER 18 database analysis. Ann Surg Oncol 2012 0.94
29 Circulating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progression. Patholog Res Int 2011 0.94
30 High-avidity antitumor T-cell generation by toll receptor 8-primed, myeloid- derived dendritic cells is mediated by IL-12 production. Surgery 2006 0.93
31 Clark level risk stratifies patients with mitogenic thin melanomas for sentinel lymph node biopsy. Ann Surg Oncol 2013 0.93
32 Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer. Ann Surg Oncol 2002 0.91
33 Dendritic cell-based vaccines: barriers and opportunities. Future Oncol 2012 0.91
34 Inhibition of CD4+CD25+ regulatory T cell function and conversion into Th1-like effectors by a Toll-like receptor-activated dendritic cell vaccine. PLoS One 2013 0.89
35 Response to HER-2 pulsed DC1 vaccines is predicted by both HER-2 and estrogen receptor expression in DCIS. Ann Surg Oncol 2013 0.88
36 Computer aided automatic detection of malignant lesions in diffuse optical mammography. Med Phys 2010 0.88
37 Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate. J Transl Med 2011 0.88
38 Radiation as immunomodulator: implications for dendritic cell-based immunotherapy. Radiat Res 2014 0.87
39 Local immune response predicts survival in patients with thick (t4) melanomas. Ann Surg Oncol 2013 0.86
40 Optical malignancy parameters for monitoring progression of breast cancer neoadjuvant chemotherapy. Biomed Opt Express 2012 0.85
41 The significance of HER-2/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive disease. J Surg Oncol 2011 0.84
42 Effect of multiple activation stimuli on the generation of Th1-polarizing dendritic cells. Hum Immunol 2010 0.84
43 Combining innate immunity with radiation therapy for cancer treatment. Clin Cancer Res 2005 0.83
44 A human ErbB2-specific T-cell receptor confers potent antitumor effector functions in genetically engineered primary cytotoxic lymphocytes. Hum Gene Ther 2014 0.83
45 Racial disparities in immediate breast reconstruction after mastectomy: impact of state and federal health policy changes. Ann Surg Oncol 2012 0.82
46 Magnetic resonance imaging-guided biopsy of mammographically and clinically occult breast lesions. Ann Surg Oncol 2002 0.82
47 Immediate reconstruction following nipple-sparing mastectomy: one option for young breast cancer patients with early stage disease. J Thorac Dis 2013 0.80
48 Outcome after treatment of patients with mammographically occult, magnetic resonance imaging-detected breast cancer presenting with axillary lymphadenopathy. Clin Breast Cancer 2004 0.80
49 Use of radiotracer for sentinel lymph node mapping in breast cancer optimizes staging independent of site of administration. Clin Nucl Med 2006 0.79
50 Extracellular ATP and Toll-like receptor 2 agonists trigger in human monocytes an activation program that favors T helper 17. PLoS One 2013 0.78
51 Method of primary tumor detection as a risk factor for local and distant recurrence after breast-conservation treatment for early-stage breast cancer. Clin Breast Cancer 2008 0.78
52 Type I-polarized BRAF-pulsed dendritic cells induce antigen-specific CD8+ T cells that impact BRAF-mutant murine melanoma. Melanoma Res 2016 0.78
53 Sartorius transposition during inguinal lymphadenectomy for melanoma. J Surg Res 2013 0.78
54 Asymptomatic changes in cardiac function can occur in ductal carcinoma-in-situ patients following treatment with HER-2/neu-pulsed dendritic cell vaccines. Am J Surg 2009 0.77
55 Dendritic cells in melanoma immunotherapy. Curr Treat Options Oncol 2005 0.77
56 Repeat operative sentinel lymph node biopsy. Clin Breast Cancer 2006 0.77
57 Mature CD83(+) dendritic cells infected with recombinant gp100 vaccinia virus stimulate potent antimelanoma T cells. Ann Surg Oncol 2002 0.76
58 Diagnosis of Melanoma. PET Clin 2011 0.76
59 It's all in for the HER family in tumorigenesis. Expert Rev Vaccines 2010 0.76
60 Sentinel lymph node biopsy in breast cancer: a work in progress. Cancer J 2015 0.75
61 Prognosis of patients with melanoma and microsatellitosis undergoing sentinel lymph node biopsy. Ann Surg Oncol 2013 0.75
62 Biopsy findings after breast conservation therapy for early-stage invasive breast cancer. Int J Radiat Oncol Biol Phys 2007 0.75
63 Racial disparities in the use of outpatient mastectomy. J Surg Res 2013 0.75
64 Developing dendritic cell-based therapies to condition immune responses to novel oncogenic proteins and stem cells. Expert Rev Clin Pharmacol 2009 0.75